The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma

[1]  C. Ko,et al.  Postoperative Complications Reduce Adjuvant Chemotherapy Use in Resectable Pancreatic Cancer , 2014, Annals of surgery.

[2]  M. Büchler,et al.  Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Jeanette W. Chung,et al.  Effect of Postoperative Complications on Adjuvant Chemotherapy Use for Stage III Colon Cancer , 2013, Annals of surgery.

[4]  M. Schäfer,et al.  Severe Postoperative Complications Adversely Affect Long-Term Survival After R1 Resection for Pancreatic Head Adenocarcinoma , 2013, World Journal of Surgery.

[5]  T. Pawlik,et al.  Impact of complications on long‐term survival after resection of colorectal liver metastases , 2013, The British journal of surgery.

[6]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[7]  Y. Murakami,et al.  Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection , 2013, Cancer Chemotherapy and Pharmacology.

[8]  E. Nakakura,et al.  Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. , 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

[9]  A. Stenzinger,et al.  Postoperative Complications Deteriorate Long-Term Outcome in Pancreatic Cancer Patients , 2012, Annals of Surgical Oncology.

[10]  M. Choti,et al.  Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer , 2012, Journal of Gastrointestinal Surgery.

[11]  F. Onder,et al.  Optimal timing of adjuvant treatment in patients with early breast cancer , 2011, Medical oncology.

[12]  M. Winget,et al.  Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada , 2011, Cancer.

[13]  W. Mackillop,et al.  Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. , 2011, JAMA.

[14]  W. Mackillop,et al.  Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer , 2011 .

[15]  H. Friess,et al.  Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. , 2010, JAMA.

[16]  H. Ohge,et al.  Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma. , 2010, Journal of the American College of Surgeons.

[17]  B. Uzzan,et al.  Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. , 2010, European journal of cancer.

[18]  J. Cameron,et al.  Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas. , 2007, International journal of radiation oncology, biology, physics.

[19]  J. Cameron,et al.  Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study , 2010, Annals of Surgical Oncology.

[20]  P. D. De Leyn,et al.  Postoperative Complications After Transthoracic Esophagectomy for Cancer of the Esophagus and Gastroesophageal Junction Are Correlated With Early Cancer Recurrence: Role of Systematic Grading of Complications Using the Modified Clavien Classification , 2009, Annals of surgery.

[21]  C. Earle,et al.  Etiology of Delays in the Initiation of Adjuvant Chemotherapy and Their Impact on Outcomes for Stage II and III Rectal Cancer , 2009, Diseases of the colon and rectum.

[22]  K. Campbell,et al.  Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  F. T. ten Kate,et al.  Postoperative Complications After Esophagectomy for Adenocarcinoma of the Esophagus Are Related to Timing of Death Due to Recurrence , 2008, Annals of surgery.

[24]  T. Eberlein.  Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial , 2008 .

[25]  Peter Neuhaus,et al.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. , 2007, JAMA.

[26]  Michael A. Choti,et al.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience , 2006, Journal of Gastrointestinal Surgery.

[27]  J. Ho,et al.  The Impact of Postoperative Complications on Long-Term Outcomes Following Curative Resection for Colorectal Cancer , 2007, Annals of Surgical Oncology.

[28]  J. Cameron,et al.  Assessment of Complications After Pancreatic Surgery: A Novel Grading System Applied to 633 Patients Undergoing Pancreaticoduodenectomy , 2006, Annals of surgery.

[29]  A. Neugut,et al.  Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer , 2006, Cancer.

[30]  K. Gelmon,et al.  Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  J. Cameron,et al.  One Thousand Consecutive Pancreaticoduodenectomies , 2006, Annals of surgery.

[32]  C. McArdle,et al.  Impact of anastomotic leakage on long‐term survival of patients undergoing curative resection for colorectal cancer , 2005, The British journal of surgery.

[33]  J. Neoptolemos,et al.  Postoperative pancreatic fistula: an international study group (ISGPF) definition. , 2005, Surgery.

[34]  Jun Yan.  Survival Analysis: Techniques for Censored and Truncated Data , 2004 .

[35]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[36]  Helen Hickey,et al.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.

[37]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[38]  M. Bonetti,et al.  Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  C. Compton.  Atlas of Tumor Pathology. Tumors of the Pancreas , 1998 .

[40]  G. Klöppel,et al.  Tumors of the Pancreas , 1997 .

[41]  J. Klein,et al.  Survival Analysis: Techniques for Censored and Truncated Data , 1997 .

[42]  R H Hruban,et al.  Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. , 1997, Annals of surgery.

[43]  S. Cha,et al.  Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. , 1993, International journal of radiation oncology, biology, physics.

[44]  D. Cox,et al.  Analysis of Survival Data. , 1985 .

[45]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .